搜尋結果
2022
Kuo, I. Y. ,
Liu, D. ,
Lai, W. W. ,
Wang, Y. C. &
Loh, Y. P. ,
2022 ,
於: Cancer Biomarkers. 33 ,
3 ,
p. 369-377 9 p. 研究成果: Article › 同行評審
Carboxypeptidase H
100%
Adenocarcinoma of Lung
63%
Lung Neoplasms
46%
Messenger RNA
33%
Biomarkers
9%
Chang, C. C. ,
Lin, C. Y. ,
Huang, L. T. ,
Chuang, M. T. ,
Lu, Y. H. ,
Huang, W. L. ,
Chen, Y. Y. ,
Lai, W. W. ,
Tseng, Y. L. &
Yen, Y. T. ,
2022 12月 ,
於: Cancer Imaging. 22 ,
1 , 56.
研究成果: Article › 同行評審
Thymic epithelial tumor
100%
ROC Curve
10%
Medical Records
5%
Dai, S. Y. ,
Tseng, Y. L. ,
Chang, C. C. ,
Huang, W. L. ,
Yen, Y. T. ,
Lai, W. W. &
Chen, Y. Y. ,
2022 , (Accepted/In press)
於: Asian Journal of Surgery. 研究成果: Article › 同行評審
Vital Capacity
100%
Forced Expiratory Volume
98%
Video-Assisted Thoracic Surgery
85%
Lung
73%
Segmental Mastectomy
25%
Chiang, H. C. ,
Lin, M. Y. ,
Lin, F. C. ,
Chiang, N. J. ,
Wang, Y. C. ,
Lai, W. W. ,
Chang, W. L. &
Sheu, B. S. ,
2022 ,
於: Nutrition and Cancer. 研究成果: Article › 同行評審
Prealbumin
100%
Transferrin
87%
Malnutrition
76%
Cohort Studies
55%
Albumins
26%
2021
Yang, S. C. ,
Lai, C. H. ,
Kuo, C. W. ,
Lin, C. C. ,
Lai, W. W. &
Wang, J. D. ,
2021 ,
於: International journal of environmental research and public health. 18 ,
8 , 4040.
研究成果: Article › 同行評審
Needle Like Crystal
100%
Cost effectiveness
99%
lesion
98%
health care
98%
Health Expenditures
96%
Tsai, J. S. ,
Su, P. L. ,
Yang, S. C. ,
Chang, C. C. ,
Lin, C. Y. ,
Yen, Y. T. ,
Tseng, Y. L. ,
Lai, W. W. ,
Lin, C. C. &
Su, W. C. ,
2021 9月 ,
於: Journal of the Formosan Medical Association. 120 ,
9 ,
p. 1729-1739 11 p. 研究成果: Article › 同行評審
Bevacizumab
100%
Propensity Score
96%
ErbB Receptors
85%
Protein-Tyrosine Kinases
81%
Non-Small Cell Lung Carcinoma
80%
Pao, T. H. ,
Chen, Y. Y. ,
Chang, W. L. ,
Chang, J. S. M. ,
Chiang, N. J. ,
Lin, C. Y. ,
Lai, W. W. ,
Tseng, Y. L. ,
Yen, Y. T. ,
Chung, T. J. &
Lin, F. C. ,
2021 5月 ,
於: PloS one. 16 ,
5 May , e0251811.
研究成果: Article › 同行評審
Esophageal Fistula
100%
Intensity-Modulated Radiotherapy
85%
Esophageal Squamous Cell Carcinoma
83%
Drug Therapy
41%
Esophageal Stenosis
22%
Chen, Y. Y. ,
Yen, Y. T. ,
Lai, W. W. ,
Huang, W. L. ,
Chang, C. C. &
Tseng, Y. L. ,
2021 10月 ,
於: Thoracic Cancer. 12 ,
20 ,
p. 2655-2665 11 p. 研究成果: Article › 同行評審
Adenocarcinoma of Lung
100%
ErbB Receptors
89%
Protein-Tyrosine Kinases
85%
Lung
50%
Survival
20%
Lai, W. W. ,
Chung, C. H. ,
Lin, C. N. ,
Yang, S. C. ,
Hwang, J. S. &
Wang, J. D. ,
2021 12月 ,
於: Journal of the Formosan Medical Association. 120 ,
12 ,
p. 2089-2099 11 p. 研究成果: Article › 同行評審
Quality-Adjusted Life Years
100%
Nasopharyngeal Neoplasms
63%
Costs and Cost Analysis
56%
Neoplasms
29%
Quality of Life
29%
Wu, C. Y. ,
Chen, Y. Y. ,
Chang, C. C. ,
Yen, Y. T. ,
Lai, W. W. ,
Huang, W. L. &
Tseng, Y. L. ,
2021 5月 18 ,
於: BMC Surgery. 21 ,
1 , 244.
研究成果: Article › 同行評審
Video-Assisted Thoracic Surgery
100%
Lung Diseases
71%
Bronchiectasis
8%
Lymphadenopathy
7%
Air
5%
Lin, C. Y. ,
Chang, C. C. ,
Liu, Y. S. ,
Chen, Y. Y. ,
Lai, W. W. ,
Tseng, Y. L. &
Yen, Y. T. ,
2021 1月 ,
於: Asian Journal of Surgery. 44 ,
1 ,
p. 131-136 6 p. 研究成果: Article › 同行評審
Segmental Mastectomy
100%
Lung
47%
Forced Expiratory Volume
33%
Residual Volume
22%
Video-Assisted Surgery
10%
2020
Wu, H. Y. ,
Pan, Y. Y. ,
Kopylov, A. T. ,
Zgoda, V. ,
Ma, M. C. ,
Wang, C. H. ,
Su, W. C. ,
Lai, W. W. ,
Cheng, P. N. &
Liao, P. C. ,
2020 7月 1 ,
於: Proteomics - Clinical Applications. 14 ,
4 , 1900095.
研究成果: Article › 同行評審
Adenocarcinoma of Lung
100%
Biological Marker
84%
Mass Spectrometry
84%
Biomarkers
60%
Marker
40%
Pao, T. H. ,
Chang, W. L. ,
Chiang, N. J. ,
Chang, J. S. M. ,
Lin, C. Y. ,
Lai, W. W. ,
Tseng, Y. L. ,
Yen, Y. T. ,
Chung, T. J. &
Lin, F. C. ,
2020 9月 22 ,
於: Radiation Oncology. 15 ,
1 , 221.
研究成果: Article › 同行評審
Intensity-Modulated Radiotherapy
100%
Esophageal Squamous Cell Carcinoma
97%
Radiation
61%
Heart
53%
Drug Therapy
48%
Yang, S. C. ,
Lai, W. W. ,
Hsu, J. C. ,
Su, W. C. &
Wang, J. D. ,
2020 4月 ,
於: PloS one. 15 ,
4 , e0231413.
研究成果: Article › 同行評審
Erlotinib Hydrochloride
100%
Afatinib
80%
Protein-Tyrosine Kinases
71%
Gefitinib
49%
Cost-Benefit Analysis
45%
Lai, W. W. ,
Lin, C. N. ,
Chang, C. C. &
Wang, J. D. ,
2020 12月 1 ,
於: Scientific reports. 10 ,
1 , 3722.
研究成果: Article › 同行評審
Costs and Cost Analysis
60%
Incidence
28%
Cost Control
24%
Survival
21%
Health Expenditures
19%
Chang, H. Y. ,
Lee, C. H. ,
Li, Y. S. ,
Huang, J. T. ,
Lan, S. H. ,
Wang, Y. F. ,
Lai, W. W. ,
Wang, Y. C. ,
Lin, Y. J. ,
Liu, H. S. &
Cheng, H. C. ,
2020 12月 ,
於: Journal of biomedical science. 27 ,
1 , 102.
研究成果: Article › 同行評審
MicroRNA
100%
Fibronectin
98%
Esophageal Squamous Cell Carcinoma
96%
Vimentin
84%
MicroRNAs
68%
Pao, T. H. ,
Chang, W. L. ,
Chiang, N. J. ,
Lin, C. Y. ,
Lai, W. W. ,
Tseng, Y. L. &
Lin, F. C. ,
2020 2月 27 ,
於: Radiation Oncology. 15 ,
1 , 48.
研究成果: Article › 同行評審
Intensity-Modulated Radiotherapy
100%
Pericardial Effusion
96%
Drug Therapy
48%
Pericardium
22%
Incidence
9%
Huang, W. L. ,
Chen, Y. Y. ,
Chang, C. C. ,
Yen, Y. T. ,
Lai, W. W. ,
Lin, B. W. ,
Lee, J. C. &
Tseng, Y. L. ,
2020 11月 ,
於: Asian Journal of Surgery. 43 ,
11 ,
p. 1069-1073 5 p. 研究成果: Article › 同行評審
Metastasectomy
100%
Rectal Neoplasms
71%
Colorectal Neoplasms
55%
Colonic Neoplasms
45%
Lung
37%
Lin, F. C. ,
Chang, W. L. ,
Chiang, N. J. ,
Lin, M. Y. ,
Chung, T. J. ,
Pao, T. H. ,
Lai, W. W. ,
Tseng, Y. L. ,
Yen, Y. T. &
Sheu, B. S. ,
2020 8月 ,
於: PloS one. 15 ,
8 August , e0237114.
研究成果: Article › 同行評審
Chemoradiotherapy
100%
Tumor Burden
89%
Radiation
70%
Survival
51%
Esophageal Squamous Cell Carcinoma
44%
2019
Liao, S. Y. ,
Kuo, I. Y. ,
Chen, Y. T. ,
Liao, P. C. ,
Liu, Y. F. ,
Wu, H. Y. ,
Lai, W. W. &
Wang, Y. C. ,
2019 10月 10 ,
於: Oncogene. 38 ,
41 ,
p. 6723-6736 14 p. 研究成果: Article › 同行評審
Protein Stability
100%
Lung Neoplasms
67%
Phosphorylation
58%
Cyclin D1
36%
adducin
27%
Tsai, T. L. ,
Huang, M. H. ,
Lee, C. Y. &
Lai, W. W. ,
2019 10月 ,
於: Journal of Clinical Medicine. 8 ,
10 , 1709.
研究成果: Article › 同行評審
Data Science
100%
APACHE
84%
Critical Care
63%
Intensive Care Units
59%
Respiration
39%
Yang, S. C. ,
Kuo, C. W. ,
Lai, W. W. ,
Lin, C. C. ,
Su, W. C. ,
Chang, S. M. &
Wang, J. D. ,
2019 11月 ,
於: Journal of Thoracic Oncology. 14 ,
11 ,
p. 1892-1900 9 p. 研究成果: Article › 同行評審
Lung Neoplasms
100%
Health
61%
Quality of Life
58%
Drug Therapy
31%
Value of Life
25%
Lin, C. Y. ,
Hwang, J. S. ,
Wang, W. C. ,
Lai, W. W. ,
Su, W. C. ,
Wu, T. Y. ,
Yao, G. &
Wang, J. D. ,
2019 1月 ,
於: Journal of the Formosan Medical Association. 118 ,
1P2 ,
p. 215-222 8 p. 研究成果: Article › 同行評審
Cancer Survivors
100%
Statistical Factor Analysis
81%
Neoplasms
29%
Electronic Health Records
23%
Head and Neck Neoplasms
22%
Su, P. L. ,
Yang, S. C. ,
Chen, Y. L. ,
Wu, Y. L. ,
Lin, C. Y. ,
Chang, W. Y. ,
Tseng, Y. L. ,
Lai, W. W. ,
Ho, C. L. ,
Lin, C. C. &
Su, W. C. ,
2019 10月 1 ,
於: Cancer medicine. 8 ,
13 ,
p. 5939-5947 9 p. 研究成果: Article › 同行評審
osimertinib
100%
Mutation
21%
Liquid Biopsy
17%
Therapeutics
10%
Survival Rate
9%
Kuo, I. Y. ,
Huang, Y. L. ,
Lin, C. Y. ,
Lin, C. H. ,
Chang, W. L. ,
Lai, W. W. &
Wang, Y. C. ,
2019 2月 18 ,
於: Journal of biomedical science. 26 ,
1 , 510.
研究成果: Article › 同行評審
DNA Repair
90%
DNA Damage
85%
Down-Regulation
68%
Esophageal Squamous Cell Carcinoma
57%
Cisplatin
52%
Lin, W. C. ,
Chen, C. W. ,
Lu, C. L. ,
Lai, W. W. ,
Huang, M. H. ,
Tsai, L. M. ,
Li, C. Y. &
Lai, C. H. ,
2019 ,
於: International Journal of COPD. 14 ,
p. 169-179 11 p. 研究成果: Article › 同行評審
Chronic Obstructive Pulmonary Disease
89%
Cohort Studies
68%
event
56%
mortality
56%
Mortality
25%
2018
Yang, S. C. ,
Lin, C. C. ,
Lai, W. W. ,
Chang, S. M. ,
Hwang, J. S. ,
Su, W. C. &
Wang, J. D. ,
2018 1月 1 ,
於: Therapeutic Advances in Medical Oncology. 10 研究成果: Article › 同行評審
ErbB Receptors
100%
Non-Small Cell Lung Carcinoma
93%
Quality of Life
67%
Gefitinib
65%
Mutation
58%
Jen, J. ,
Liu, C. ,
Chen, Y. ,
Wu, L. ,
Shieh, Y. ,
Lai, W. &
Wang, Y. ,
2018 ,
於: Cell Death and Differentiation. 研究成果: Article › 同行評審
Su, P. L. ,
Wu, Y. L. ,
Chang, W. Y. ,
Ho, C. L. ,
Tseng, Y. L. ,
Lai, W. W. ,
Su, W. C. ,
Lin, C. C. &
Yang, S. C. ,
2018 1月 1 ,
於: Therapeutic Advances in Medical Oncology. 10 研究成果: Article › 同行評審
Protein-Tyrosine Kinases
100%
Non-Small Cell Lung Carcinoma
98%
Afatinib
76%
Gefitinib
62%
Mutation
61%
Tzeng, H. T. ,
Su, C. C. ,
Chang, C. P. ,
Lai, W. W. ,
Su, W. C. &
Wang, Y-C. ,
2018 10月 1 ,
於: International Journal of Cancer. 143 ,
7 ,
p. 1753-1763 11 p. 研究成果: Article › 同行評審
Exocytosis
100%
Lung Neoplasms
70%
Macrophages
62%
Phenotype
53%
Neoplasms
28%
Cho, S. ,
Kuo, I. ,
Lu, P. F. ,
Tzeng, H. ,
Lai, W. ,
Su, W. &
Wang, Y. ,
2018 9月 1 ,
於: Cell death & disease. 9 ,
9 研究成果: Article › 同行評審
Lin, T. H. ,
Huang, W. L. ,
Chang, C. C. ,
Yen, Y. T. ,
Lai, W. W. ,
Tseng, Y. L. &
Chen, Y. Y. ,
2018 6月 1 ,
於: Journal of Thoracic Disease. 10 ,
6 ,
p. 3722-3728 7 p. 研究成果: Article › 同行評審
Bronchopulmonary Sequestration
100%
Video-Assisted Thoracic Surgery
86%
Segmental Mastectomy
78%
Rare Diseases
11%
Length of Stay
8%
Wang, Y. ,
Tzeng, H. ,
Tsai, C. ,
Cheng, H. ,
Lai, W. ,
Liu, H. &
Wang, Y. ,
2018 11月 1 ,
於: Cancer Letters. 437 ,
p. 79-88 研究成果: Article › 同行評審
2017
Huang, M. H. ,
Lai, C. H. ,
Lin, P. I. &
Lai, W. W. ,
2017 1月 1 ,
於: Formosan Journal of Surgery. 50 ,
1 ,
p. 21-27 7 p. 研究成果: Article › 同行評審
Lactic Acid
100%
Critical Care
98%
Mortality
56%
Intensive Care Units
31%
Odds Ratio
12%
Chang, W. L. ,
Lai, W. W. ,
Kuo, I. Y. ,
Lin, C. Y. ,
Lu, P. J. ,
Sheu, B. S. &
Wang, Y. C. ,
2017 6月 1 ,
於: Journal of Gastroenterology. 52 ,
6 ,
p. 705-714 10 p. 研究成果: Article › 同行評審
Esophageal Squamous Cell Carcinoma
100%
Chemoradiotherapy
90%
DNA Methylation
83%
Biomarkers
54%
Methylation
30%
Liao, S. Y. ,
Chiang, C. W. ,
Hsu, C. H. ,
Chen, Y. T. ,
Jen, J. ,
Juan, H. F. ,
Lai, W. W. &
Wang, Y. C. ,
2017 10月 12 ,
於: Oncogene. 36 ,
41 ,
p. 5722-5733 12 p. 研究成果: Article › 同行評審
Zinc Fingers
100%
Oncogene Proteins
99%
Lung Neoplasms
69%
Serine
13%
Phosphorylation
9%
Yang, S. C. ,
Lai, W. W. ,
Lin, C. C. ,
Su, W. C. ,
Ku, L. J. ,
Hwang, J. S. &
Wang, J. D. ,
2017 6月 1 ,
於: Lung Cancer. 108 ,
p. 183-191 9 p. 研究成果: Article › 同行評審
Cost-Benefit Analysis
87%
Lung Neoplasms
80%
Tomography
68%
Life Expectancy
66%
Quality-Adjusted Life Years
55%
Tzeng, H. T. ,
Tsai, C. H. ,
Yen, Y. T. ,
Cheng, H. C. ,
Chen, Y. C. ,
Pu, S. W. ,
Wang, Y. S. ,
Shan, Y. S. ,
Tseng, Y. L. ,
Su, W. C. ,
Lai, W. W. ,
Wu, L. W. &
Wang, Y. C. ,
2017 5月 1 ,
於: Clinical Cancer Research. 23 ,
9 ,
p. 2335-2345 11 p. 研究成果: Article › 同行評審
Thrombospondin 1
100%
Endothelial Cells
55%
Exocytosis
47%
Tumor Microenvironment
44%
Esophageal Squamous Cell Carcinoma
37%
Jen, J. ,
Tang, Y. A. ,
Lu, Y. H. ,
Lin, C. C. ,
Lai, W. W. &
Wang, Y. C. ,
2017 ,
於: Molecular cancer. 16 ,
1 , 104.
研究成果: Article › 同行評審
Long Noncoding RNA
100%
Adenocarcinoma of Lung
98%
Lung Neoplasms
73%
Cell Movement
42%
Cell Proliferation
20%
Tzeng, H. T. ,
Li, T. H. ,
Tang, Y. A. ,
Tsai, C. H. ,
Lu, P. J. F. ,
Lai, W. W. ,
Chiang, C. W. &
Wang, Y. C. ,
2017 ,
於: Oncotarget. 8 ,
65 ,
p. 108556-108570 15 p. 研究成果: Article › 同行評審
Protein Kinase C-alpha
100%
Tissue Inhibitor of Metalloproteinase-1
87%
Exocytosis
81%
Protein Kinases
57%
Phosphorylation
50%
Lin, C. Y. ,
Yang, S. C. ,
Lai, W. W. ,
Su, W. C. &
Wang, J. D. ,
2017 3月 1 ,
於: Journal of Health Psychology. 22 ,
4 ,
p. 397-408 12 p. 研究成果: Article › 同行評審
WHO
99%
cancer
97%
psychometrics
91%
quality of life
85%
Lung Neoplasms
84%
Wang, Y. T. ,
Chen, J. ,
Chang, C. W. ,
Jen, J. ,
Huang, T. Y. ,
Chen, C. M. ,
Shen, R. ,
Liang, S. Y. ,
Cheng, I. C. ,
Yang, S. C. ,
Lai, W. W. ,
Cheng, K. H. ,
Hsieh, T. S. ,
Lai, M. Z. ,
Cheng, H. C. ,
Wang, Y. C. &
Chen, R. H. ,
2017 8月 1 ,
於: Journal of Clinical Investigation. 127 ,
8 ,
p. 2982-2997 16 p. 研究成果: Article › 同行評審
Tumor Microenvironment
95%
Immunosuppressive Agents
76%
Leukemia
75%
Lung Neoplasms
54%
Neoplasms
29%
2016
Kuo, I. Y. ,
Jen, J. ,
Hsu, L. H. ,
Hsu, H. S. ,
Lai, W. W. &
Wang, Y. C. ,
2016 8月 2 ,
於: Journal of biomedical science. 23 ,
1 , 58.
研究成果: Article › 同行評審
Adenocarcinoma of Lung
100%
DNA Methylation
92%
Biological Marker
84%
Biomarkers
60%
Population
36%
Hung, M. C. ,
Lai, W. W. ,
Chen, H. H. W. ,
Lee, J. C. ,
Lin, Y. J. ,
Hsiao, J. R. ,
Cheng, Y. M. ,
Shan, Y. S. ,
Su, W. C. &
Wang, J. D. ,
2016 8月 1 ,
於: Journal of the Formosan Medical Association. 115 ,
8 ,
p. 609-618 10 p. 研究成果: Article › 同行評審
Cost-Benefit Analysis
87%
Quality-Adjusted Life Years
79%
Gross Domestic Product
60%
Costs and Cost Analysis
35%
Neoplasms
32%
Chang, J. M. ,
Kam, K. H. ,
Yen, Y. T. ,
Huang, W. L. ,
Chen, W. ,
Tseng, Y. L. ,
Wu, M. H. ,
Lai, W. W. &
Gonzalez-Rivas, D. ,
2016 ,
於: Medicine (United States). 95 ,
40 , e5097.
研究成果: Article › 同行評審
Video-Assisted Thoracic Surgery
100%
Lung
53%
Lung Neoplasms
31%
Postoperative Care
23%
Segmental Mastectomy
22%
Yang, S. C. ,
Lai, W. W. ,
Hsiue, T. R. ,
Su, W. C. ,
Lin, C. K. ,
Hwang, J. S. &
Wang, J. D. ,
2016 6月 1 ,
於: Quality of Life Research. 25 ,
6 ,
p. 1441-1449 9 p. 研究成果: Article › 同行評審
Clinical Practice
100%
cancer
98%
Non-Small Cell Lung Carcinoma
96%
quality of life
86%
Quality of Life
69%
Lin, C. H. ,
Tsai, C. H. ,
Yeh, C. T. ,
Liang, J. L. ,
Hung, W. C. ,
Lin, F. C. ,
Chang, W. L. ,
Li, H. Y. ,
Yao, Y. C. ,
Hsu, T. I. ,
Lee, Y. C. ,
Wang, Y. C. ,
Sheu, B. S. ,
Lai, W. W. ,
Calkins, M. J. ,
Hsiao, M. &
Lu, P. J. ,
2016 ,
於: Oncotarget. 7 ,
26 ,
p. 39680-39693 14 p. 研究成果: Article › 同行評審
Esophageal Squamous Cell Carcinoma
100%
Radiation Tolerance
24%
Therapeutics
13%
Animal Disease Models
13%
Receptor Protein-Tyrosine Kinases
11%
Lai, C. H. ,
Lai, W. W. ,
Chiou, M. J. ,
Lin, W. C. ,
Yang, Y. J. ,
Li, C. Y. &
Tsai, L. M. ,
2016 7月 ,
於: Annals of the Rheumatic Diseases. 75 ,
7 ,
p. 1350-1356 7 p. 研究成果: Article › 同行評審
Percutaneous
100%
Systemic Lupus Erythematosus
67%
Rheumatoid Arthritis
59%
Cohort Studies
48%
Hospital Mortality
22%
2015
Wang, M. C. ,
Chang, Y. H. ,
Wu, C. C. ,
Tyan, Y. C. ,
Chang, H. C. ,
Goan, Y. G. ,
Lai, W. W. ,
Cheng, P. N. &
Liao, P. C. ,
2015 2月 6 ,
於: Journal of Thoracic Oncology. 10 ,
2 ,
p. 286-301 16 p. 研究成果: Article › 同行評審
Non-Small Cell Lung Carcinoma
66%
Cell Movement
60%
Biomarkers
48%
Lung Neoplasms
24%
Neoplasms
23%
Chang, J. M. ,
Lai, W. W. ,
Yen, Y. T. ,
Tseng, Y. L. ,
Chen, Y. Y. ,
Wu, M. H. ,
Chen, W. &
Light, R. W. ,
2015 9月 1 ,
於: Medicine (United States). 94 ,
37 研究成果: Article › 同行評審
Primary Spontaneous Pneumothorax
100%
Video-Assisted Thoracic Surgery
87%
Pneumothorax
25%